458 related articles for article (PubMed ID: 25993178)
41. Off-Label Megestrol in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
Garcia JM; Shamliyan TA
Am J Med; 2018 Jun; 131(6):623-629.e1. PubMed ID: 29784194
[No Abstract] [Full Text] [Related]
42. Omega-3 Fatty Acids in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
Garcia JM; Shamliyan TA
Am J Med; 2017 Oct; 130(10):1151-1155. PubMed ID: 29016347
[No Abstract] [Full Text] [Related]
43. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
Reuter SE; Martin JH
Clin Pharmacokinet; 2016 Jul; 55(7):807-812. PubMed ID: 26883879
[TBL] [Abstract][Full Text] [Related]
44. Treatment of anorexia with megestrol acetate.
Tchekmedyian NS
Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
[TBL] [Abstract][Full Text] [Related]
45. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
[TBL] [Abstract][Full Text] [Related]
46. [The effect of blocking TNF-alpha in patients with cancer-related cachexia and anorexia].
Gueta I; Altman A; Shoenfeld Y
Harefuah; 2010 Aug; 149(8):512-4, 551, 550. PubMed ID: 21341430
[TBL] [Abstract][Full Text] [Related]
47. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
48. What is cancer anorexia-cachexia syndrome? A historical perspective.
Bennani-Baiti N; Walsh D
J R Coll Physicians Edinb; 2009 Sep; 39(3):257-62. PubMed ID: 20608345
[TBL] [Abstract][Full Text] [Related]
49. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT
Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046
[TBL] [Abstract][Full Text] [Related]
50. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis.
Bai Y; Hu Y; Zhao Y; Yu X; Xu J; Hua Z; Zhao Z
Support Care Cancer; 2017 May; 25(5):1651-1659. PubMed ID: 28074289
[TBL] [Abstract][Full Text] [Related]
51. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs.
Ming-Hua C; Bao-Hua Z; Lei Y
Curr Pharm Biotechnol; 2016; 17(13):1147-1152. PubMed ID: 27758689
[TBL] [Abstract][Full Text] [Related]
53. Opportunities for targeting the fatigue-anorexia-cachexia symptom cluster.
Alesi ER; del Fabbro E
Cancer J; 2014; 20(5):325-9. PubMed ID: 25299142
[TBL] [Abstract][Full Text] [Related]
54. Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C
Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373
[TBL] [Abstract][Full Text] [Related]
55. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.
Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E
J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820
[TBL] [Abstract][Full Text] [Related]
56. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG
J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749
[TBL] [Abstract][Full Text] [Related]
57. A systematic review of health-related quality of life instruments in patients with cancer cachexia.
Wheelwright S; Darlington AS; Hopkinson JB; Fitzsimmons D; White A; Johnson CD
Support Care Cancer; 2013 Sep; 21(9):2625-36. PubMed ID: 23797577
[TBL] [Abstract][Full Text] [Related]
58. [Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients].
Nauck F; Klaschik E
Schmerz; 2004 Jun; 18(3):197-202. PubMed ID: 15221423
[TBL] [Abstract][Full Text] [Related]
59. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
[TBL] [Abstract][Full Text] [Related]
60. Update on the treatment of cancer cachexia.
Nishie K; Nishie T; Sato S; Hanaoka M
Drug Discov Today; 2023 Sep; 28(9):103689. PubMed ID: 37385369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
